CE Credit Hours: 12.00 CPEUs
Commission on Dietetic Registration (CDR) - Provider #21328, Activity #158115 approved for 12 CPEUs.
CPEU Course Description
Migraine belongs to the primary headaches, representing one of the most disabling disorders worldwide. This CPEU course summarizes the influence of female and male sex hormones on primary headaches, provides an overview of genome-wide associated studies in migraine, investigates the ability of endogenous mediators to provoke migraine, explores the effectiveness of aerobic exercise in migraine relief, reviews the role of calcitonin gene-related peptide in the cardiovascular system in order to understand the effect of blockade with monoclonal antibodies in migraineurs, and identifies patterns of cannabis treatment.
Morgan O’Hara, M.S., R.D.N., C.D.N. was involved in the creation of this course.
Article Author: Nico Sollmann, M.D., et al.
Exam writer: Tiev LaGuire, M.S.
CPEU Course Objectives
1. Describe how cannabinoids and terpenes influence the activity of one another, resulting in strain-specific characteristics.
2. Explain the “opioid-sparing effect” of cannabinoids.
3. Express which molecule, administered before menstruation, postponed migraine attacks.
4. Identify which nutrient deficiency can increase menstrual migraine attack frequency.
5. List three phytoestrogens that could have a beneficial effect on migraine.
6. Name which prostaglandin was unable to evoke migraine-like attacks in patients.
7. Provide which contraceptive strategy should not be used to reduce headache.
8. Recognize which two supplements have been shown to have migraine-protective effects by reversible abnormalities in mitochondrial functioning.
This course expires on 09/25/2023
CPE Level: II
Learning Codes: 2010, 2050, 2100, 5420
Performance Indicators (RDN): 6.2.5, 8.1.2 , 8.1.5 , 8.2.4
Performance Indicators (NTDR): 6.2.5, 8.1.2 , 8.2.4 , 8.3.6
Course Date: 2019-07-09
Our courseware includes the text content found on our websites as well as video, audio, and exam questions that make up our courses. You can link to and access our courseware free of charge for personal use. You may not modify or redistribute our courseware under any circumstances.
Although we allow free access for personal use, you may not use our courseware for any commercial purposes without an agreement in place. This includes (but is not limited to) using our courseware for internal training, redistributing our courseware for sale, and copying all or parts of any of our courseware.
If you're interested in licensing our content for commercial purposes or have any other questions, please contact firstname.lastname@example.org.
We will disclose, in advance, any proprietary interest in any product, instrument, device, service, or material to be discussed during the learning event, as well as the source of any third-party compensation related to the presentation. This policy applies to both our organization and contractors. If such proprietary/financial interests exist, we will publish a disclaimer in marketing or instructional materials for a course.
No conflict of interest was identified for this learning activity for individuals in a position to control content.
In order to view this course, you will need to be able to view a PDF document for the course material. If your device doesn't have the capability to view a PDF, you can click here to download Adobe Acrobat for free.
If you require ADA or other special needs accommodations, please contact us by email: email@example.com or by phone 1-800-413-9373, so arrangements can be made.
The board approval status information is provided based on our current understanding of the licensing agencies. Please note that it is the responsibility of each licensee to verify acceptance of our courses with their licensing agency.